共 139 条
[1]
Calo LA(2014)Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter’s and Gitelman’s syndromes, human models of endogenous angiotensin II signaling antagonism J Hypertens 32 2109-2119
[2]
Davis PA(2014)Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients J Hypertens 32 331-338
[3]
Rossi GP(2016)Pathophysiological effects of RhoA and Rho-associated kinase on cardiovascular system J Hypertens 34 3-10
[4]
Calo LA(2006)Rho kinases in cardiovascular physiology and pathophysiology Circ Res 98 322-334
[5]
Davis PA(2010)The role of Rho protein signaling in hypertension Nat Rev Cardiol 7 637-647
[6]
Pagnin E(2015)The blocking of angiotensin II type 1 receptor and RhoA/Rho kinase activity in hypertensive patients: effect of olmesartan medoxomil and implication with cardiovascular-renal remodeling J Renin Angiotensin Aldosterone Syst 16 1245-1250
[7]
Dal Maso L(2014)Galphaq signalling: the new and the old Cell Signal 26 833-848
[8]
Maiolino G(1993)Inositol trisphosphate and calcium signalling Nature 361 315-325
[9]
Seccia TM(2005)The guanine nucleotide exchange factor p63RhoGEF, a specific link between Gq/11-coupled receptor signaling and RhoA J Biol Chem 280 11134-11139
[10]
Pessina AC(2012)p63RhoGEF: a new switch for G(q)-mediated activation of smooth muscle Trends Cardiovasc Med 22 122-127